Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 18.57 million as of January 22, 2025. Its market cap has decreased by -68.54% in one year.

Market Cap

18.57M

Enterprise Value

27.97M

Revenue

16.99M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.35

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 18.57M, a decrease of -89.06%. That is a compound annual growth rate of -21.99%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	18.57M	-12.04%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	74.69M	-64.39%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	169.60B
GSK plc	55.45B
Haleon	33.80B
Smith & Nephew	8.94B
ConvaTec Group	4.95B
Hikma Pharmaceuticals	4.63B
HUTCHMED (China)	2.00B
Oxford Nanopore Technologies	1.37B

Market Cap Rankings